Related Experiment Video
Updated: Jul 19, 2026
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Molecular markers for renal cell carcinoma
Reviews in Urology
|September 21, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.
Prostate cancer and prostatic diseases·2015
[Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2014
Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.
Evidence-based complementary and alternative medicine : eCAM·2013
Cryptozoospermia Associated With Genital Tucking Behavior in a Transwoman.
Reviews in urology·2021
Contemporary Management of Bulbar Urethral Strictures.
Reviews in urology·2021
Heat shock protein family D member 1 (HSPD1) modulates ribosome-related pathways and protein synthesis in lung adenocarcinoma.
Molecular and cellular biochemistry·2026
Patient-reported outcomes in clinical trials leading to breast cancer drug approvals: are we making them count?
Breast cancer research and treatment·2026
Sex-specific associations of the bilirubin-to-albumin ratio with lung cancer risk: evidence from Cox regression and causal survival forest analysis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
DHRS2 regulates epithelial-mesenchymal transition in breast cancer cells.
Molecular biology reports·2026